235 related articles for article (PubMed ID: 31228250)
21. Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis.
Loomba R; Wesley R; Bain A; Csako G; Pucino F
Clin Gastroenterol Hepatol; 2009 Apr; 7(4):487-493. PubMed ID: 19250986
[TBL] [Abstract][Full Text] [Related]
22. A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
Das A
Am J Gastroenterol; 1998 Oct; 93(10):1895-900. PubMed ID: 9772051
[TBL] [Abstract][Full Text] [Related]
23. [Spontaneous bacterial peritonitis].
Skladaný Ľ; Kasová S; Purgelová A; Bystrianska N; Adamcová-Selčanová S
Klin Mikrobiol Infekc Lek; 2016 Dec; 22(4):136-140. PubMed ID: 28147426
[TBL] [Abstract][Full Text] [Related]
24. Primary and secondary prophylaxis of spontaneous bacterial peritonitis: current state of the art.
Facciorusso A; Antonino M; Orsitto E; Sacco R
Expert Rev Gastroenterol Hepatol; 2019 Aug; 13(8):751-759. PubMed ID: 31304804
[No Abstract] [Full Text] [Related]
25. Evaluation of prophylactic antibiotic regimens on recurrence and mortality in spontaneous bacterial peritonitis.
Glaess SS; Attridge RL; Brady RL; Attridge RT
Ann Hepatol; 2019; 18(6):841-848. PubMed ID: 31611065
[TBL] [Abstract][Full Text] [Related]
26. Short- and long-term predictors of spontaneous bacterial peritonitis in Singapore.
Wong YJ; Kalki RC; Lin KW; Kumar R; Tan J; Teo EK; Li JW; Ang TL
Singapore Med J; 2020 Aug; 61(8):419-425. PubMed ID: 31363784
[TBL] [Abstract][Full Text] [Related]
27. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic strategies and emergence of multiresistant bacterial strains.
Salerno F; Cazzaniga M
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S45-51. PubMed ID: 20865474
[TBL] [Abstract][Full Text] [Related]
29. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
[TBL] [Abstract][Full Text] [Related]
30. Role of Rifaximin in Spontaneous Bacterial Peritonitis Prevention.
Oliver A; Wong M; Sanchez C
South Med J; 2018 Nov; 111(11):660-665. PubMed ID: 30392000
[TBL] [Abstract][Full Text] [Related]
31. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
[TBL] [Abstract][Full Text] [Related]
32. Bacteremia in Patients With Liver Cirrhosis: Prevalence and Predictors of Multidrug Resistant Organisms.
Addo Smith JN; Yau R; Russo HP; Putney K; Restrepo A; Garey KW; Sofjan AK
J Clin Gastroenterol; 2018 Aug; 52(7):648-654. PubMed ID: 29176351
[TBL] [Abstract][Full Text] [Related]
33. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
[TBL] [Abstract][Full Text] [Related]
34. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.
Fiore M; Gentile I; Maraolo AE; Leone S; Simeon V; Chiodini P; Pace MC; Gustot T; Taccone FS
Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):329-336. PubMed ID: 29303883
[TBL] [Abstract][Full Text] [Related]
35. [Spontaneous bacterial peritonitis].
Velkey B; Vitális E; Vitális Z
Orv Hetil; 2017 Jan; 158(2):50-57. PubMed ID: 28088889
[TBL] [Abstract][Full Text] [Related]
36. Difficult to treat spontaneous bacterial peritonitis.
Shalimar ; Acharya SK
Trop Gastroenterol; 2013; 34(1):7-13. PubMed ID: 23923368
[TBL] [Abstract][Full Text] [Related]
37. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
38. Optimizing Antibiotic Duration for Spontaneous Bacterial Peritonitis Prophylaxis: Time to Rethink.
Gangwani MK; Aziz A; Priyanka F; Lee Smith W; Aziz M; Hassan M
Am J Ther; 2023 Sep-Oct 01; 30(5):e492-e494. PubMed ID: 37713708
[No Abstract] [Full Text] [Related]
39. Longitudinal Assessment of Multidrug-Resistant Organisms in Newly Admitted Nursing Facility Patients: Implications for an Evolving Population.
Mody L; Foxman B; Bradley S; McNamara S; Lansing B; Gibson K; Cassone M; Armbruster C; Mantey J; Min L
Clin Infect Dis; 2018 Aug; 67(6):837-844. PubMed ID: 29635360
[TBL] [Abstract][Full Text] [Related]
40. [Spontaneous bacterial peritonitis].
Šenkeříková R; Fraňková S; Šperl J; Špičák J
Vnitr Lek; 2015 Feb; 61(2):134-40. PubMed ID: 25813257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
